Macrophage migration inhibitory factor expression in cervical cancer

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 5, 2010, Pages 651-657

  Krockenberger, Mathias ^a   Engel, Jörg B ^a   Kolb, Julia ^a   Dombrowsky, Yvonne ^a   Häusler, Sebastian F M ^a   Kohrenhagen, Nico ^a   Dietl, Johannes ^a   Wischhusen, Jörg ^a   Honig, Arnd ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cervical cancer; Cervical dysplasia; Cervical intraepithelial neoplasia; Immune system; Macrophage migration inhibitory factor (MIF)

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CARCINOMA IN SITU; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX DYSPLASIA; WESTERN BLOTTING; FEMALE; METABOLISM; PATHOLOGY; TUMOR CELL LINE; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

CARCINOMA IN SITU; CELL LINE, TUMOR; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS;

EID: 77950467099     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0702-5     Document Type: Article

References (29)

1. Agarwal R, Whang DH, Alvero AB Visintin I, Lai Y, Segal EA, Schwartz P, Ward D, Rutherford T, Mor G (2007) Macrophage migration inhibitory factor expression in ovarian cancer. Am J Obstet Gynecol 196:348.e1-e5
2. Bartfeld H, Atoynatan T (1971) Activity and properties of macrophage migration inhibitory factor produced by mixed lymphocyte cultures. Nat New Biol 230(16):246-247
3. Binsky I, Haran M, Starlets D, Gore Y, Lantner F, Harpaz N, Leng L, Goldenberg DM, Shvidel L, Berrebi A, Bucala R, Shachar I (2007) IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival. Proc Natl Acad Sci USA 104:13408-13413
4. Camlica H, Duranyildiz D, Oguz H, Oral EN, Yasasever V (2008) The diagnostic value of macrophage migration inhibitory factor (MIF) in gastric cancer. Pathol Oncol Res 14:79-83
5. Coleman AM, Rendon BE, Zhao M, Qian MW, Bucala R, Xin D, Mitchell RA (2008) Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase. J Immunol 181:2330-2337
6. Fingerle-Rowson G, Petrenko O, Metz CN, Forsthuber TG, Mitchell R, Huss R, Moll U, Müller W, Bucala R (2003) The p53- dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc Natl Acad Sci USA 100:9354-9359
7. Hagemann T, Wilson J, Kulbe H, Li NF, Leinster DA, Charles K, Klemm F, Pukrop T, Binder C, Balkwill FR (2005) Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol 175:1197-1205
8. James RM, Cruickshank ME, Siddiqui N (2008) Guideline Development Group. Management of cervical cancer: summary of SIGN guidelines. BMJ 336:41-43
9. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics. CA Cancer J Clin 58:71-96
10. Krockenberger M, Dombrowski Y, Weidler C, Ossadnik M, Hönig A, Häusler S, Voigt H, Becker JC, Leng L, Steinle A, Weller M, Bucala R, Dietl J, Wischhusen J (2008) Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D. J Immunol 180:7338-7348
11. Lee H, Rhee H, Kang HJ, Kim HS, Min BS, Kim NK, Kim H (2008) Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas. Am J Clin Pathol 129:772-779
12. Long HJ 3rd (2007) Management of metastatic cervical cancer: review of the literature. J Clin Oncol 25:2966-2974
13. Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L, Fingerle-Rowson G, Bucala R, Lüscher B, Bernhagen J (2007) Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene 26:5046-5059
14. Meyer-Siegler KL, Vera PL, Iczkowski KA, Bifulco C, Lee A, Gregersen PK, Leng L, Bucala R (2007) Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence. Genes Immun 8:646-652
15. Mitchell RA (2004) Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell Signal 16:13-19
16. Muramaki M, Miyake H, Yamada Y, Hara I (2006) Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and disease progression. Oncol Rep 15:253-257
17. Nedergaard BS, Ladekarl M, Nyengaard JR, Nielsen K (2008) A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years. Gynecol Oncol 108:106-111
18. Papageorgiou PS, Henley WL, Glade PR (1972) Production and characterization of migration inhibitory factor(s) (MIF) of established lymphoid and non-lymphoid cell lines. J Immunol 108:494-504
19. Petrenko O, Moll UM (2005) Macrophage migration inhibitory factor MIF interferes with the Rb-E2F pathway. Mol Cell 17:225-236
20. Ren Y, Tsui HT, Poon RT, Ng IO, Li Z, Chen Y, Jiang G, Lau C, Yu WC, Bacher M, Fan ST (2003) Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma. Int J Cancer 107:22-29
21. Rendon BE, Roger T, Teneng I, Zhao M, Al-Abed Y, Calandra T, Mitchell RA (2007) Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J Biol Chem 12:282(41):29910-29918
22. Sun B, Nishihira J, Yoshiki T, Kondo M, Sato Y, Sasaki F, Todo S (2005) Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway. Clin Cancer Res 11:1050-1058
23. Textor S, Dürst M, Jansen L, Accardi R, Tommasino M, Trunk MJ, Porgador A, Watzl C, Gissmann L, Cerwenka A (2008) Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer. Int J Cancer 123:2343-2353
24. Wilson JM, Coletta PL, Cuthbert RJ, Scott N, MacLennan K, Hawcroft G, Leng L, Lubetsky JB, Jin KK, Lolis E, Medina F, Brieva JA, Poulsom R, Markham AF, Bucala R, Hull MA (2005) Macrophage migration inhibitory factor promotes intestinal tumorigenesis. Gastroenterology 129:1485-1503 (Pubitemid 41597391)
25. Winner M, Meier J, Zierow S, Rendon BE, Crichlow GV, Riggs R, Bucala R, Leng L, Smith N, Lolis E, Trent JO, Mitchell RA (2008) A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells. Cancer Res 68(18):7253-7257
26. Xu X, Wang B, Ye C, Yao C, Lin Y, Huang X, Zhang Y, Wang S (2008) Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Cancer Lett 261:147-157 (Pubitemid 351253721)
27. Yu DS, Hsieh DS, Chang SY (2006a) Increasing expression of GSTpi MIF, and ID1 genes in chemoresistant prostate cancer cells. Arch Androl 52:275-281
28. Yu DS, Lin JC, Hsieh DS, Chang SY, Lee CF (2006b) Modulation of MDR-1 gene by MIF and GSTpi with drug resistance generation in hormone independent prostate cancer. Arch Androl 52:283-291
29. Zhou Q, Yan X, Gershan J, RJ Orentas, BD Johnson (2008) Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo. J Immunol 181:1877-1886